Depression in type 2 diabetes mellitus: prevalence, impact, and treatment (Q38410193)

2 September 2017

1 reference

title

Depression in type 2 diabetes mellitus: prevalence, impact, and treatment (English)

1 reference

2 September 2017

1 reference

4

Patrick J Lustman

1 reference

2 September 2017

Katherine Semenkovich

series ordinal

1

1 reference

2 September 2017

Miriam E Brown

series ordinal

2

1 reference

2 September 2017

Dragan M Svrakic

series ordinal

3

1 reference

2 September 2017

language of work or name

1 reference

1 April 2015

1 reference

2 September 2017

1 reference

2 September 2017

75

1 reference

2 September 2017

577-587

1 reference

2 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-015-0347-4

2 September 2017

0 references

cites work

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Psychiatric disorders and diabetes--results from a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

History of depression increases risk of type 2 diabetes in younger adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depressive symptoms and risk of type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression and risk for onset of type II diabetes. A prospective population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression and type 2 diabetes over the lifespan: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

National trends in second-generation antipsychotic augmentation for nonpsychotic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Associations between anxiety, depression, and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Hypercortisolemia and hippocampal changes in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Hypercortisolemic depression is associated with the metabolic syndrome in late-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The HPA axis in major depression: classical theories and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Adult hippocampal neurogenesis buffers stress responses and depressive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Hippocampal volume reduction and HPA-system activity in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Effects of diabetes on hippocampal neurogenesis: links to cognition and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression and poor glycemic control: a meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Correlates of health-related quality of life in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Effect of comorbid depression on quality of life in adults with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Assessing psychosocial distress in diabetes: development of the diabetes distress scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Relationship of depression and diabetes self-care, medication adherence, and preventive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Validity of medication adherence self-reports in adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Patients with type 2 diabetes at risk for major depressive disorder over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression and advanced complications of diabetes: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression and coronary heart disease in women with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Depression and incident diabetic retinopathy: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The association of comorbid depression with mortality in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Proportion of antidepressants prescribed without a psychiatric diagnosis is growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

National patterns in antidepressant medication treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Efficacy of antidepressants in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Review: benefits of antidepressants over placebo limited except in very severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

RETRACTED: Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

A review of empirically supported psychological therapies for mood disorders in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

National trends in the outpatient treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Standards of medical care in diabetes--2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

A review of treating depression in diabetes: emerging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0347-4

Association of depression and diabetes complications: a meta-analysis

21 January 2018

1 reference

12 December 2020

The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity

1 reference

12 December 2020

Bidirectional association between depression and type 2 diabetes mellitus in women

1 reference

12 December 2020

Antidepressant use in persons aged 12 and over: United States, 2005-2008

1 reference

12 December 2020

Risk factors for heart disease and stroke among diabetic persons, by disability status

1 reference

12 December 2020

Specificity of depressotypic cognitions in clinical depression.

1 reference

12 December 2020

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

1 reference

12 December 2020

Predicting response to cognitive behavior therapy of depression in type 2 diabetes

1 reference

12 December 2020

Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults

1 reference

12 December 2020

Antidepressant drugs 'work', but they are not clinically effective

1 reference

12 December 2020

Major depression and impaired glucose tolerance

1 reference

12 December 2020

Meta-analysis: Its strengths and limitations.

1 reference

12 December 2020

Depressive symptoms and mortality among persons with and without diabetes

1 reference

12 December 2020

Depression and the reporting of diabetes symptoms

1 reference

12 December 2020

Depression and all-cause and coronary heart disease mortality among adults with and without diabetes

1 reference

12 December 2020

Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression

1 reference

12 December 2020

10.1007/S40265-015-0347-4

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference